Home
Editorial
Services
Interview
Q&A
Chronicle Specials
Pharma Mart
ePharmail
Archives
Tenders & Project
Tenders & Enquiries
Pharma Projects
Corporate
Company Profiles
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
Join Pharma
|
Login
Home
>
News
you can get e-magazine links on WhatsApp.
Click here
News
VectorY Therapeutics receives US FDA clearance to proceed with PIONEER-ALS phase 1/2 clinical trial of VTx-002
,
December 05, 2025
iOnctura initiates phase I/II trial of roginolisib in patients with myelofibrosis who are no longer responding to JAK inhibition
,
December 05, 2025
AstraZeneca advances haematology and cell therapy ambition with largest-ever presence at ASH
,
December 05, 2025
Jazz Pharma to present pivotal phase 3 results of Ziihera combinations in first-line HER2-positive locally advanced or metastatic GEA at 2026 ASCO GI symposium
,
December 04, 2025
China NMPA approves Antengene’ IND application for phase Ib/II study of ATG-022 in combo with Keytruda± chemotherapy
,
December 03, 2025
Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia
,
December 03, 2025
GSK to present new data from its haematology portfolio at the 67th ASH Annual Meeting and Exposition
,
December 03, 2025
Bristol Myers Squibb data at ASH 2025 showcase potential of haematology pipeline and build momentum for next generation portfolio
,
December 02, 2025
Merck showcases data for Alzheimer’s disease candidates MK-2214 and MK-1167 at CTAD 2025
,
December 02, 2025
Ideaya Biosciences receives US FDA clearance to initiate phase 1 trial to evaluate IDE034, a potential first-in-class bispecific B7H3/PTK7 TOP1 ADC targeting multiple solid tumour types
,
December 02, 2025
Generate:Biomedicines to begin global phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI
,
December 02, 2025
Gan & Lee Pharmaceuticals begins GRADUAL-3 phase 3 study of first Chinese once-monthly GLP-1 RA for weight management
,
December 01, 2025
InnoCare begins patient dosing in global phase II trial of TYK2 inhibitor, Soficitinib to treat prurigonodularis
,
December 01, 2025
Renalys Pharma reports positive results from phase III study of sparsentan in Japanese patients with IgA nephropathy
,
November 28, 2025
Chugai Pharma announces results from phase I/II study in Japan to evaluate the efficacy and safety of Port Delivery System with Ranibizumab in patients with nAMD & DME
,
November 27, 2025
Novo Nordisk announces phase 2 clinical trial results of amycretin in people with type 2 diabetes
,
November 27, 2025
NeuroSense receives US FDA clearance to begin pivotal phase 3 trial for PrimeC in ALS
,
November 26, 2025
Pin Therapeutics begins patient dosing in phase 1 clinical trial of CK1a degrader PIN-5018
,
November 25, 2025
Merck to present new data across multiple hematologic malignancies at ASH Annual Meeting in Orlando, from December 6-9
,
November 25, 2025
Bayer’s asundexian meets primary efficacy and safety endpoints in landmark phase III OCEANIC-STROKE study in secondary stroke prevention
,
November 25, 2025
Results Found:
16684
1
2
3
4
5
Go to
Total Number of Pages:
835
Loading...
×
Copyright © 2024 Saffron Media Pvt. Ltd |
About us
|
Contact us
|
Advertise
|
Feedback
|
Helpdesk
|
Disclaimer
|
Sitemap
|
Archives
|
Terms & Conditions